Background The subcutaneous implantable cardioverter-defibrillator system (S-ICD) uses a novel detection algorithm previously shown to discriminate induced tachyarrhythmias (ventricular vs supraventricular) effectively. Objective The purpose of this study was to evaluate the role of the S-ICD discrimination algorithm in reducing the incidence of spontaneous inappropriate shocks. Methods A total of 314 subjects underwent implantation with an S-ICD system as part of the S-ICD Clinical Investigation (IDE Trial). Subjects were grouped according to programming at discharge to either a single shock zone or 2 shock zones, with a discrimination algorithm in the lower rate zone. Results This cohort had 226 subjects (72%) with dual zone programming and 88 subjects (28%) with single zone programming. Over a mean follow-up period of 661 ± 174 days, inappropriate shocks occurred in 23 subjects from the dual zone subgroup (10.2%) and 23 subjects from the single zone subgroup (26.1%, P <.001), with 2-year inappropriate shock-free rates of 89.7% vs 73.6%;,respectively (hazard ratio 0.38, P =.001). Freedom from appropriate shocks did not differ between subgroups (92.2% vs 90.3%, hazard ratio 0.82, P =.64). Moreover, mean time to appropriate therapy did not differ between subgroups, and there was only 1 episode of arrhythmic syncope in the cohort. Conclusion The addition of a second shock zone with an active discrimination algorithm was strongly associated with a reduction in inappropriate shocks with the S-ICD system and did not result in prolongation of detection times or increased syncope. These data support the use of dual zone programming as a standard setting for S-ICD patients.

Inappropriate shock, Inappropriate therapy, Oversensing, Rhythm discrimination, Subcutaneous implantable-defibrillator, Supraventricular tachyarrhythmia,
Heart Rhythm
Department of Cardiology

Gold, M.R, Weiss, R, Theuns, D.A.M.J, Smith, W.M, Leon, A, Knight, B.P, … Burke, M.C. (2014). Use of a discrimination algorithm to reduce inappropriate shocks with a subcutaneous implantable cardioverter-defibrillator. Heart Rhythm, 11(8), 1352–1358. doi:10.1016/j.hrthm.2014.04.012